The distinctive nature of HER2-positive gastric cancers

被引：13
|
作者：
Marano, L. [1 ]
Roviello, F. [1 ]
机构：
[1] Univ Siena, Dept Med Surg & Neurosci, Unit Gen & Minimally Invas Surg, I-53100 Siena, Italy
来源：
EJSO | 2015年 / 41卷 / 03期
关键词：
HER2; EXPRESSION; RECEPTOR; PROTEIN;
D O I：
10.1016/j.ejso.2014.12.007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：271 / 273
页数：3
相关论文
共 50 条
  • [21] Trastuzumab deruxtecan for the treatment of HER2-positive gastric cancer
    Mishima, Saori
    Shitara, Kohei
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (07) : 825 - 830
  • [22] Emerging insights into mechanisms of trastuzumab resistance in HER2-positive cancers
    Wu, Xiaoxue
    Huang, Shuting
    He, Weiling
    Song, Mei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 122
  • [23] Pertuzumab (Perjeta®) approval in HER2-positive metastatic breast cancers
    Sabatier, Renaud
    Goncalves, Anthony
    BULLETIN DU CANCER, 2014, 101 (7-8) : 765 - 771
  • [24] Challenges and future of HER2-positive gastric cancer therapy
    Ma, Chenzhe
    Wang, Xiao
    Guo, Jiwu
    Yang, Bo
    Li, Yumin
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [25] Therapeutic Advances and Challenges in the Management of HER2-Positive Gastroesophageal Cancers
    Chuang, Jeremy
    Klempner, Samuel
    Waters, Kevin
    Atkins, Katelyn
    Chao, Joseph
    Cho, May
    Hendifar, Andrew
    Gangi, Alexandra
    Burch, Miguel
    Mehta, Pareen
    Gong, Jun
    DISEASES, 2022, 10 (02)
  • [26] Pathophysiological role of ion channels and transporters in HER2-positive breast cancer
    Zhou, Zhengxing
    Zhang, Chengmin
    Ma, Zhiyuan
    Wang, Hu
    Tuo, Biguang
    Cheng, Xiaoming
    Liu, Xuemei
    Li, Taolang
    CANCER GENE THERAPY, 2022, 29 (8-9) : 1097 - 1104
  • [27] HER2-positive gastric cancer identified by serum HER2: A case report
    Saito, Mayuko
    Kawakami, Yujiro
    Yamashita, Kentaro
    Nasuno, Hiroshi
    Ishimine, Yu
    Fukuda, Koichiro
    Isshiki, Hiroyuki
    Suzuki, Ryo
    Arimura, Yoshiaki
    Shinomura, Yasuhisa
    ONCOLOGY LETTERS, 2016, 11 (06) : 3575 - 3578
  • [28] Ebselen oxide and derivatives are new allosteric HER2 inhibitors for HER2-positive cancers
    Blasquez, Lucas
    Bouzinba-Segard, Haniaa
    Bourdoulous, Sandrine
    Faure, Camille
    MOLECULAR ONCOLOGY, 2023, 17 (10) : 1981 - 1999
  • [29] Clinicopathological features and Borrmann classification associated with HER2-positive in primary gastric cancer
    Dai, Xiaomin
    Zhang, Xijiong
    Yu, Jin
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2019, 12 : 287 - 294
  • [30] Clinicopathological factors associated with HER2-positive gastric cancer: A meta-analysis
    Wang, Hong-Bo
    Liao, Xiao-Feng
    Zhang, Jian
    MEDICINE, 2017, 96 (44)
12345